Skip to contentApplication 217003
- Type
- NDA
- Sponsor
- PHARMACYCLICS INC
Application Products#
Product, Drug, Ingredient table| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|
| 001 | IMBRUVICA | IBRUTINIB | SUSPENSION;ORAL | 70MG/ML | No | No |
| 002 | IMBRUVICA | IBRUTINIB | CAPSULE;ORAL | 70MG | No | No |
| 003 | IMBRUVICA | IBRUTINIB | CAPSULE;ORAL | 140MG | No | No |
| 004 | IMBRUVICA | IBRUTINIB | TABLET;ORAL | 140MG | No | No |
| 005 | IMBRUVICA | IBRUTINIB | TABLET;ORAL | 230MG | No | No |
| 006 | IMBRUVICA | IBRUTINIB | TABLET;ORAL | 420MG | No | No |
| 007 | IMBRUVICA | IBRUTINIB | TABLET;ORAL | 560MG | No | No |
NDC Listings For This Application#
NDC, Name, Nonproprietary name table| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|
| 57962-007 | Imbruvica | Ibrutinib | Pharmacyclics LLC | NDA | Current |
| 57962-007 | Imbruvica | Ibrutinib | Pharmacyclics LLC | NDA | Current |
Documents#
Document, Submission type, Date table| Document | Submission type | Date |
|---|
| 83995 | SUPPL | 2025-10-31 |
| 83883 | SUPPL | 2025-10-23 |
| 80732 | SUPPL | 2024-12-26 |
| 80728 | SUPPL | 2024-12-26 |
| 78464 | SUPPL | 2024-05-14 |
| 77610 | SUPPL | 2024-02-23 |
| 77609 | SUPPL | 2024-02-23 |
| 74474 | ORIG | 2023-06-12 |
| 73810 | ORIG | 2023-03-21 |
| 71891 | ORIG | 2022-08-25 |